Cathie Wood Watch: Ark unloads a favorite


Famed investor Cathie Wood, CEO of Ark Investment Management, pulled one of her favorite stocks from the market on Jan. 23, perhaps in an attempt to capitalize on the recent uptick.

Ark funds dumped 175,491 Exact Sciences shares (EXAS) – Get a free report, a medical diagnostics company famous for its home colon cancer test. That cat was valued at $11.9 million as of the Jan. 23 close.

The stock lost 11% over the past year, but is up 119% since Oct. 14, supported by strong gains and the market’s overall rally. Exact Sciences is the largest holding in Wood’s flagship Ark Innovation ETF (ARKK) – Get a free report.



Please enter your comment!
Please enter your name here